Brief: Boundless Bio Announces Portfolio Prioritization And Runway Extension
23/05/2025 21:54
Boundless Bio Inc BOLD.O: BOUNDLESS BIO ANNOUNCES PORTFOLIO PRIORITIZATION AND RUNWAY EXTENSION BOUNDLESS BIO INC - PRIORITIZES BBI-355/BBI-825 COMBINATION AND BBI-940 BOUNDLESS BIO INC - DISCONTINUES CURRENT ARMS OF BBI-355 IN POTENTIATE TRIAL BOUNDLESS BIO INC - TO EVALUATE BBI-355/BBI-825 COMBINATION IN 2025 BOUNDLESS BIO INC - REDUCES WORKFORCE BY ONE-THIRD Source text: ID:nGNX8ZRbgN Further company coverage: BOLD.O
Recent news on Boundless Bio
See all newsBoundless Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Boundless Bio Inc expected to post a loss of 58 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Bath & Body Works, Avis Budget, Cerebras
U.S. STOCKS ON THE MOVE-Boundless Bio, Galectin, UniQure
Boundless Bio soars on merger with Serapha